Takeda’s Entyvio (vedolizumab) Receives the MHLW Approval for the Maintenance Treatment of Moderate to Severe Ulcerative Colitis
Shots: The MHLW has approved the use of Entyvio (SC) as maintenance therapy for th...
Shots: The MHLW has approved the use of Entyvio (SC) as maintenance therapy for th...
Shots: The EC has approved Libtayo in combination with Pt-based CT for adult patie...
Shots: The NICE has issued final draft guidance recommending Tezspire for use with...
Shots: The approval was based on the P-III trials (POETYK PSO-1 & 2) evaluatin...
Shots: The MHLW has approved Enhertu (HER2 directed ADC) for HER2 low (IHC 1+ or I...
Shots: The US FDA has approved Joenja (selective PI3Kδ inhibitor) for APDS i...
Incisive News in 3 Shots.